comparemela.com

Latest Breaking News On - Kazia therapeutics ltd - Page 7 : comparemela.com

EQS-News: Kazia Therapeutics talks positive pre-clinical data for EVT801

EQS-News: Kazia Therapeutics Ltd Kazia Therapeutics talks positive pre-clinical data for EVT801 06.12.2022 / 17:45 CET/CEST The issuer is solely responsible for the content of this announcement. Contact DetailsProactive InvestorsJonathan Jackson+61 413 713 744Jonathan@proactiveinvestors.comNews .

United statesJonathan jacksonNews serviceKazia therapeutics ltdDistribution servicesCorporate newsRegulatory announcementsEqs newsEt cestAckson 61

Kazia Therapeutics talks positive pre-clinical data for EVT801

EQS-News: Kazia Therapeutics Ltd Kazia Therapeutics talks positive pre-clinical data for EVT801 06.12.2022 / 17:45 CET/CEST The issuer is solely responsible for the content of. | December 6, 2022

Jonathan jacksonKazia therapeutics ltdDistribution servicesCorporate newsRegulatory announcementsKazia therapeutics limited stock exchangePress releaseOntent kza au000000kza9

Kazia Therapeutics Ltd welcomes publication of positive pre-clinical data for EVT801 in peer-reviewed cancer research journal

Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) is encouraged by the publication of positive pre-clinical data for EVT801, its clinical-stage drug.

University cancer institute of toulouse oncopoleKazia therapeutics ltdCancer research communicationsUniversity cancer institute

Kazia Therapeutics Ltd welcomes publication of positive pre-clinical data for EVT801 in peer-reviewed cancer research journal

Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) is encouraged by the publication of positive pre-clinical data for EVT801, its clinical-stage drug.

University cancer institute of toulouse oncopoleKazia therapeutics ltdCancer research communicationsUniversity cancer institute

Kazia Therapeutics Ltd takes Phase 2 study of paxalisib international; opens two sites in Australia

Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has expanded its Phase 2 study investigating the effect of paxalisib on diffuse intrinsic pontine glioma.

United statesChimerix incKazia therapeutics ltdOncology consortiumPacific pediatric neuro oncology consortiumKazia therapeutics

vimarsana © 2020. All Rights Reserved.